MGO One Seven’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $568K | Buy |
7,266
+604
| +9% | +$47.2K | 0.02% | 675 |
|
|
2025
Q1 | $483K | Buy |
6,662
+4
| +0.1% | +$290 | 0.02% | 640 |
|
|
2024
Q4 | $493K | Buy |
6,658
+931
| +16% | +$68.9K | 0.02% | 620 |
|
|
2024
Q3 | $378K | Buy |
5,727
+65
| +1% | +$4.29K | 0.02% | 677 |
|
|
2024
Q2 | $523K | Buy |
5,662
+395
| +7% | +$36.5K | 0.02% | 535 |
|
|
2024
Q1 | $503K | Sell |
5,267
-668
| -11% | -$63.8K | 0.03% | 515 |
|
|
2023
Q4 | $453K | Buy |
5,935
+1,246
| +27% | +$95K | 0.03% | 560 |
|
|
2023
Q3 | $325K | Sell |
4,689
-50
| -1% | -$3.46K | 0.03% | 583 |
|
|
2023
Q2 | $447K | Sell |
4,739
-815
| -15% | -$76.9K | 0.04% | 450 |
|
|
2023
Q1 | $460K | Buy |
5,554
+885
| +19% | +$73.2K | 0.03% | 505 |
|
|
2022
Q4 | $348K | Sell |
4,669
-114
| -2% | -$8.51K | 0.03% | 506 |
|
|
2022
Q3 | $395 | Sell |
4,783
-168
| -3% | -$14 | 0.02% | 451 |
|
|
2022
Q2 | $471K | Sell |
4,951
-15,850
| -76% | -$1.51M | 0.07% | 333 |
|
|
2022
Q1 | $2.45M | Buy |
20,801
+4,160
| +25% | +$490K | 0.26% | 93 |
|
|
2021
Q4 | $2.16M | Buy |
16,641
+3,360
| +25% | +$435K | 0.22% | 111 |
|
|
2021
Q3 | $1.59M | Buy |
13,281
+1,197
| +10% | +$143K | 0.2% | 132 |
|
|
2021
Q2 | $1.25M | Buy |
12,084
+6,972
| +136% | +$722K | 0.18% | 152 |
|
|
2021
Q1 | $427K | Buy |
+5,112
| New | +$427K | 0.07% | 329 |
|
|
2019
Q1 | – | Sell |
-654
| Closed | -$33K | – | 775 |
|
|
2018
Q4 | $33K | Buy |
+654
| New | +$33K | 0.01% | 755 |
|
|
2018
Q1 | $36K | Hold |
774
| – | – | 0.02% | 691 |
|
|
2017
Q4 | $29K | Buy |
+774
| New | +$29K | 0.01% | 759 |
|